|

ETB-DualNK-01 Clinical Trials

1 actively recruiting trial

Also known as: Dual-target anti-PSMA/PSCA CAR-NK cells

Pipeline

Phase 1: 1

Top Sponsors

  • Beijing Biotech1

Indications

  • PSCA-positive Prostate Cancer1
  • Advanced Prostate Adenocarcinoma1
  • PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer1
  • Metastatic Castration-resistant Prostate Cancer1
  • Cancer1

Other1 trial

Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.